Benjamin Hanisch

Benjamin Hanisch

Auto-generated profile, based on publicly available information

Benjamin Hanisch

Division of Infectious Diseases, Children’s National Hospital, Washington, DC

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2017 in Journal of the Pediatric Infectious Diseases Society
Verified
Journal Article
Open access
PDF file
CDChristopher Duplessis
Christopher Duplessis
BBBiswajit Biswas
Biswajit Biswas
BHB Hanisch
B Hanisch
MPM Perkins
M Perkins
MHM Henry
M Henry
THT Hamilton
T Hamilton
Here, we report a complex case that involved a pediatric patient who experienced recalcitrant multidrug-resistant Pseudomonas aeruginosa infection complicated by bacteremia/sepsis; our antibacterial options were limited because of resistance, allergies, and suboptimal source control. A cocktail of 2 bacteriophages targeting the infectious organism introduced on 2 separate occasions sterilized the bacteremia.

13 October 2017 in BMC Medicine
Verified
Journal Article
Open access
PDF file
ESEstela Shabani
Estela Shabani
BHBenjamin Hanisch
Benjamin Hanisch
RORobert O. Opoka
Robert O. Opoka
TLThomas Lavstsen
Thomas Lavstsen
CJChandy C. John
Chandy C. John
Expression of group A and the A-like subset of group B Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is associated with severe malaria (SM). The diversity of var sequences combined with the challenges of distinct classification of patient pathologies has made studying the role of distinct PfEMP1 variants on malaria disease severity challenging. The application of retinopathy in the recent years has provided a further method to clinically evaluate children with cerebral malaria (CM). The question of whether children with clinical CM but no retinopathy represent a completely different disease process or a subgroup within the spectrum of CM remains an important question in malaria. In the current study, we use newly designed primer sets with the best coverage to date in a large cohort of children with SM to determine the role of var genes in malaria disease severity and especially CM as discriminated by retinopathy. We performed qRT-PCR targeting the different subsets of these var genes on samples from Ugandan children with CM (n = 98, of whom 50 had malarial retinopathy [RP] and 47 did not [RN]), severe malarial anemia (SMA, n = 47), and asymptomatic parasitemia (AP, n = 14). The primers used in this study were designed based on var sequences from 226 Illumina whole genome sequenced P. falciparum field isolates. Increasing severity of illness was associated with increasing levels of endothelial protein C receptor (EPCR)-binding PfEMP1. EPCR-binding PfEMP1 transcript levels were highest in children with combined CM and SMA and then decreased by level of disease severity: RP CM > RN CM > SMA > AP. The study findings indicate that PfEMP1 binding to EPCR is important in the pathogenesis of SM, including RN CM, and suggest that increased expression of EPCR-binding PfEMP1 is associated with progressively more severe disease. Agents that block EPCR-binding of PfEMP1 could provide novel interventions to prevent or decrease disease severity in malaria.

13 July 2022 in American Journal of Transplantation
Verified
Journal Article
Open access
Marwan M. AzarMarwan M. Azar
Marwan M. Azar
STSarah Turbett
Sarah Turbett
DGDavid Gaston
David Gaston
MGMelissa Randy Gitman
Melissa Randy Gitman
RRRaymund R. Razonable
Raymund R. Razonable
DKDeepali Kumar
Deepali Kumar
The last decade has seen an explosion of advanced assays for the diagnosis of infectious diseases, yet evidence-based recommendations to inform their optimal use in the care of transplant recipients are lacking. A consensus conference sponsored by the American Society of Transplantation (AST) was convened on December 7, 2021, to define the utility of novel infectious disease diagnostics in organ transplant recipients. The conference represented a collaborative effort by experts in transplant infectious diseases, diagnostic stewardship, and clinical microbiology from centers across North America to evaluate current uses, unmet needs, and future directions for assays in 5 categories including (1) multiplex molecular assays, (2) rapid antimicrobial resistance detection methods, (3) pathogen-specific T-cell reactivity assays, (4) next-generation sequencing assays, and (5) mass spectrometry-based assays. Participants reviewed and appraised available literature, determined assay advantages and limitations, developed best practice guidance largely based on expert opinion for clinical use, and identified areas of future investigation in the setting of transplantation. In addition, attendees emphasized the need for well-designed studies to generate high-quality evidence needed to guide care, identified regulatory and financial barriers, and discussed the role of regulatory agencies in facilitating research and implementation of these assays. Findings and consensus statements are presented.

1 July 2017 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
GPGregory S Park
Gregory S Park
RORobert O Opoka
Robert O Opoka
ESEstela Shabani
Estela Shabani
AWAlexis Wypyszynski
Alexis Wypyszynski
BHBenjamin Hanisch
Benjamin Hanisch
CJChandy C John
Chandy C John
Malaria retinopathy has been proposed as marker of “true” cerebral malaria (CM), ie, coma due to Plasmodium falciparum vs coma due to other causes, with incidental P falciparum parasitemia. Plasma P falciparum histidine-rich protein-2 (PfHRP2) concentrations distinguish retinopathy-positive (RP) from retinopathy-negative (RN) CM but have not been compared between RN CM and other forms of severe malaria or asymptomatic parasitemia (AP). We compared plasma PfHRP2 concentrations in 260 children with CM (247 examined for retinopathy), 228 children with severe malarial anemia (SMA), and 30 community children with AP. Plasmodium falciparum HRP2 concentrations were higher in children with RP CM than RN CM (P = .006), with an area under the receiver operating characteristic curve of 0.61 (95% confidence interval, 0.53–0.68). Plasmodium falciparum HRP2 concentrations and sequestered parasite biomass were higher in RN CM than SMA (both P < .03) or AP (both P < .001). Plasmodium falciparum HRP2 concentrations are higher in children with RN CM than in children with SMA or AP, suggesting that P falciparum is involved in disease pathogenesis in children with CM. Plasmodium falciparum HRP2 concentrations may provide a more feasible and consistent assessment of the contribution of P falciparum to severe disease than malaria retinopathy.

1 February 2024 in Journal of the Pediatric Infectious Diseases Society
Verified
Journal Article
Open access
PDF file
AHAlice Jenh Hsu
Alice Jenh Hsu
BHBenjamin R Hanisch
Benjamin R Hanisch
BFBrian T Fisher
Brian T Fisher
AHAnna R Huppler
Anna R Huppler
Invasive fungal disease (IFD) remains a significant cause of morbidity and mortality in children undergoing transplantation. There is a growing armamentarium of novel antifungal agents recently approved for use or in late stages of clinical development. The overarching goal of this review is to discuss the mechanisms of action, spectrum of activity, stage of development, and pediatric-specific data for the following agents: encochleated amphotericin B deoxycholate, fosmanogepix, ibrexafungerp, isavuconazole, olorofim, opelconazole, oteseconazole, and rezafungin. Additionally, key drug attributes of these novel agents and their potential future therapeutic roles in pediatric transplant recipients are discussed.

17 February 2020 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
JWJulie K. Weisman
Julie K. Weisman
RNRobert Sheppard Nickel
Robert Sheppard Nickel
DDDeepika S. Darbari
Deepika S. Darbari
BHBenjamin R. Hanisch
Benjamin R. Hanisch
YDYaser A. Diab
Yaser A. Diab